Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation

• Publication date

  2005-07-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.104.492488PMID 16027259PMCID PMC1472405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thromboxane A 2 and Prostacyclin Biosynthesis in Children and Adolescents With Pulmonary Vascular Disease

  2005cited by this paper
• Effect of 5-lipoxygenase on the development of pulmonary hypertension in rats.

  2004cited by this paper
• Genetic basis of pulmonary arterial hypertension: current understanding and future directions.

  2004cited by this paper
• Clinical classification of pulmonary hypertension.

  2004cited by this paper
• Pulmonary Hypertension in Transgenic Mice Expressing a Dominant-Negative BMPRII Gene in Smooth Muscle

  2004cited by this paper
• Thromboxane A2-Induced Inhibition of Voltage-Gated K+ Channels and Pulmonary Vasoconstriction: Role of Protein Kinase C&zgr;

  2003cited by this paper
• Consequences of knocking out BMP signaling in the mouse

  2003cited by this paper
• Primary pulmonary hypertension.

  2003cited by this paper
• Bone Morphogenetic Protein-7 Inhibits Constitutive and Interleukin-1β-Induced Monocyte Chemoattractant Protein-1 Expression in Human Mesangial Cells: Role for JNK/AP-1 Pathway 1

  2003cited by this paper
• Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension.

  2002cited by this paper
• 用FEV6．0代替FVC诊断气道阻塞和肺功能受限[英]／Swanney MP…∥Am J Respir Crit Care Med．

  2002cited by this paper
• Expression of 5-lipoxygenase in pulmonary artery endothelial cells.

  2002cited by this paper
• BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

  2001cited by this paper
• Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

  2000cited by this paper
• Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

  2000cited by this paper
• In situ localization and regulation of thromboxane A(2) synthase in normal and LPS-primed lungs.

  2000cited by this paper
• Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family

  2000cited by this paper
• BMP type II receptor is required for gastrulation and early development of mouse embryos.

  2000cited by this paper
• Primary Pulmonary Hypertension

  1999cited by this paper
• Arachidonic Acid Is Preferentially Metabolized by Cyclooxygenase-2 to Prostacyclin and Prostaglandin E2 *

  1999cited by this paper
• 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension.

  1998cited by this paper
• Primary pulmonary hypertension between inflammation and cancer.

  1998cited by this paper
• Pulmonary hypertension and inflammation.

  1998cited by this paper
• Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.

  1997cited by this paper
• Primary pulmonary hypertension.

  1997cited by this paper
• Bone morphogenetic proteins: multifunctional regulators of vertebrate development.

  1996cited by this paper
• The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.

  1994cited by this paper
• Thromboxane A2 and Prostacyclin Biosynthesis in Children and Adolescents With Pulmonary Vascular Disease

  1993cited by this paper
• An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.

  1992cited by this paper
• Immunoquantitation of thromboxane synthase in human tissues.

  1991cited by this paper
• Thromboxane synthase : from isolation to function

  1990cited by this paper
• Immunoquantitation of thromboxane synthase in human tissues.

  1990cited by this paper
• The transforming growth factor-beta family.

  1990cited by this paper
• Primary Pulmonary Hypertension

  1988cited by this paper
• Novel regulators of bone formation: molecular clones and activities.

  1988cited by this paper
• Primary pulmonary hypertension.

  1987cited by this paper
• Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child.

  1985cited by this paper
• Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension.

  1985cited by this paper
• Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

  1983cited by this paper
• Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension.

  1983cited by this paper
• Prostaglandins and thromboxanes.

  1979cited by this paper
• Prostaglandins and thromboxanes.

  1978cited by this paper
• Prostaglandins and Thromboxanes

  1977cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper
• Bone: Formation by Autoinduction

  1965cited by this paper

• Harnessing NLRX1: a new frontier in mitigating inflammation in pulmonary hypertension

  2025cites this paper
• Inhibiting TGF-β signaling pathway for disease therapy: challenges and opportunities.

  2025cites this paper
• Experimental animal models and patient-derived platforms to bridge preclinical discovery and translational therapeutics in pulmonary arterial hypertension

  2025cites this paper
• STING Contributes to Pulmonary Hypertension by Targeting the Interferon and BMPR2 Signaling through Regulating F2RL3.

  2024cites this paper
• Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR

  2024cites this paper
• Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension

  2023cites this paper
• The endothelium in lung fibrosis: a core signaling hub in disease pathogenesis?

  2023cites this paper
• ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport

  2023cites this paper
• Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice

  2022cites this paper
• Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling

  2022cites this paper
• The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure

  2022cites this paper
• Defining the Clinical Validity of Genes Reported to Cause Pulmonary Arterial Hypertension

  2022cites this paper
• The SOX17 phenotype in pulmonary arterial hypertension: lessons for pathobiology and clinical management

  2022cites this paper
• Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension

  2022influential citation
• New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis

  2022cites this paper
• An evolutionary machine learning for pulmonary hypertension animal model from arterial blood gas analysis

  2022cites this paper
• Approaches to treat pulmonary arterial hypertension by targeting bmpr2 - from cell membrane to nucleus.

  2021cites this paper
• The Protective of hUC- MSCs Derived Exosomes on Pulmonary Vascular Remodeling in Experimental Pulmonary Hypertension

  2021cites this paper
• Developmental programming of DNA methylation and gene expression patterns is associated with extreme cardiovascular tolerance to anoxia in the common snapping turtle

  2021cites this paper
• Animal models of pulmonary hypertension: Getting to the heart of the problem

  2021cites this paper
• Improving Right Ventricular Function by Increasing BMP Signaling with FK506.

  2021cites this paper
• Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling

  2020cites this paper
• Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension

  2020cites this paper
• The integrated stress response in pulmonary disease

  2020cites this paper
• Formulation and Characterization of Solid Lipid Nanoparticles Loading RF22-c, a Potent and Selective 5-LO Inhibitor, in a Monocrotaline-Induced Model of Pulmonary Hypertension

  2020cites this paper
• Targeting transforming growth factor-β receptors in pulmonary hypertension

  2020cites this paper
• ‘There and Back Again’—Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension

  2020cites this paper
• A new treatment for severe pulmonary arterial hypertension based on an old idea: inhibition of 5-lipoxygenase

  2020cites this paper
• Downregulation of miR-98 contributes to hypoxic pulmonary hypertension by targeting ALK1

  2019cites this paper
• Silencing PDK1 limits hypoxia-induced pulmonary arterial hypertension in mice via the Akt/p70S6K signaling pathway.

  2019cites this paper
• Genetics and genomics of pulmonary arterial hypertension

  2019cites this paper
• TUG1 Regulates Pulmonary Arterial Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension.

  2019cites this paper
• Phenotypically-Silent Bone Morphogenetic Protein Receptor 2 (Bmpr2) Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing The Risk for Neointimal Transformation.

  2019cites this paper
• Cytokines trigger disruption of endothelium barrier function and p38 MAP kinase activation in BMPR2-silenced human lung microvascular endothelial cells

  2019cites this paper
• Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation- Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation

  2019cites this paper
• Pulmonary Hypertension

  2019cites this paper
• Hypoxia‐induced Pulmonary Hypertension in Different Mouse Strains: Relation to Transcriptome

  2019cites this paper
• CLIC4/Arf6 Pathway

  2018cites this paper
• A pro-con debate: current controversies in PAH pathogenesis at the American Thoracic Society International Conference in 2017.

  2018cites this paper
• Bone Morphogenetic Proteins in Vascular Homeostasis and Disease.

  2018cites this paper
• Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension

  2018cites this paper
• TGF-β Signaling in Control of Cardiovascular Function.

  2018cites this paper
• BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series)

  2018cites this paper
• The cancer theory of pulmonary arterial hypertension

  2017cites this paper
• Challenges in the development of chronic pulmonary hypertension models in large animals

  2017cites this paper
• TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling

  2017cites this paper
• Bone Morphogenetic Protein Signaling in Pulmonary Arterial Hypertension

  2017cites this paper
• Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled

  2017cites this paper
• Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations

  2017cites this paper
• Bone morphogenetic protein signalling in pulmonary hypertension: advances and therapeutic implications

  2017cites this paper
• MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.

  2017cites this paper
• Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report

  2017cites this paper
• BMP Signaling in Pulmonary Hypertension : Advances and Therapeutic Implications

  2017cites this paper
• The role of non-coding RNA in the development of pulmonary arterial hypertension

  2016cites this paper
• Axis inhibition protein 2 deficiency leads to hypoxic pulmonary hypertension through &bgr;-catenin signaling pathway

  2016cites this paper
• Lung Circulation.

  2016cites this paper
• BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension

  2016cites this paper
• Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension.

  2016cites this paper
• BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators

  2016cites this paper
• Genotype-Phenotype Effects of Bmpr2 Mutations on Disease Severity in Mouse Models of Pulmonary Hypertension

  2016cites this paper
• Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.

  2016cites this paper
• Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.

  2016cites this paper
• In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug

  2016influential citation
• Aberrant TGFβ/BMP signalling in connective tissue disease associated pulmonary hypertension

  2015cites this paper
• BMPR2 spruces up the endothelium in pulmonary hypertension

  2015cites this paper
• Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension

  2015cites this paper
• UC San Francisco UC San Francisco Previously Published Works Title Targeting BMP signalling in cardiovascular disease and anaemia

  2015cites this paper
• 15‐Lipoxygenase Promotes Chronic Hypoxia‐Induced Phenotype Changes of PASMCs Via Positive Feedback‐Loop of BMP4

  2015cites this paper
• Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.

  2015cites this paper
• Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension

  2014cites this paper
• Pulmonary vascular function in insulin resistance and diabetes.

  2014cites this paper
• Estrogen metabolism in pulmonary arterial hypertension

  2014cites this paper
• The role of microRNA in the development of pulmonary arterial hypertension: studies in cell culture and animal models.

  2014cites this paper
• Pathology, Pathobiology and Pathophysiology of Pulmonary Arterial Hypertension

  2014cites this paper
• Functional Changes in Pulmonary Arterial Endothelial Cells Associated with BMPR2 Mutations

  2014cites this paper
• Leukotrienes in pulmonary arterial hypertension

  2014cites this paper
• Bone Morphogenetic Protein Signaling Protects against Cerulein-Induced Pancreatic Fibrosis

  2014influential citation
• BMP Pathway Regulation of and by Macrophages

  2014cites this paper
• Validation of phosphodiesterase isozymes as targets for pulmonary hypertension.

  2013cites this paper
• Role of Bone Morphogenetic Protein Type II Receptor Signaling inPulmonary Arterial Hypertension

  2013cites this paper
• Rodent models of group 1 pulmonary hypertension.

  2013cites this paper
• Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.

  2013cites this paper
• Blocking Macrophage Leukotriene B4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension

  2013cites this paper
• Therapeutic Efficacy of AAV 1 . SERCA 2 a in Monocrotaline-Induced Pulmonary Arterial Hypertension

  2013cites this paper
• SMAD1 Deficiency in Either Endothelial or Smooth Muscle Cells Can Predispose Mice to Pulmonary Hypertension

  2013cites this paper
• A Molecular Mechanism for Therapeutic Effects of cGMP-elevating Agents in Pulmonary Arterial Hypertension*

  2013cites this paper
• Role of Bone Morphogenetic Protein Type II Receptor Signaling in Pulmonary Arterial Hypertension

  2013cites this paper
• Deletion of the Sequence Encoding the Tail Domain of the Bone Morphogenetic Protein type 2 Receptor Reveals a Bone Morphogenetic Protein 7-Specific Gain of Function

  2013cites this paper
• Protein Kinase C Inhibitors as Modulators of Vascular Function and Their Application in Vascular Disease

  2013cites this paper
• TGF-β Signaling in Physiological and Pathological Angiogenesis

  2013cites this paper
• Pulmonary Arterial Hypertension: Challenges in Translational Research and a Vision for Change

  2013cites this paper
• Pulmonary hypertension: pathophysiology and signaling pathways.

  2013cites this paper
• Therapeutic Efficacy of AAV1.SERCA2a in Monocrotaline-Induced Pulmonary Arterial Hypertension

  2013cites this paper
• Heme oxygenase-1 induces 15-lipoxygenase expression during hypoxia-induced pulmonary hypertension.

  2013cites this paper
• Development and pathologies of the arterial wall

  2013cites this paper
• Vascular remodeling in pulmonary hypertension

  2013cites this paper
• Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension

  2012cites this paper
• Alteraciones vasculares pulmonares e hipertensión pulmonar en modelos de diabetes

  2012cites this paper
• The MicroRNA-328 Regulates Hypoxic Pulmonary Hypertension by Targeting at Insulin Growth Factor 1 Receptor and L-Type Calcium Channel-&agr;1C

  2012cites this paper
• Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension

  2012cites this paper